Diabetes News You Can Use

New tool IDs diabetes patients at risk for hypoglycemia hospitalization

Researchers used data from electronic medical records to develop a new risk-stratification tool that was able to identify a type 2 diabetes patient’s 12-month risk of being hospitalized for hypoglycemia based on the following risk factors: age, chronic kidney disease stage, insulin use, number of prior episodes of hypoglycemia-related utilization, prior year emergency department use and sulfonylurea use. The findings in JAMA Internal Medicine were based on data from 206,435 diabetes patients in the Kaiser Permanente Northern California health system.

MedPage Today (free registration) (8/21)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Research shows benefits of continuous glucose monitoring in diabetes

A study in the Annals of Internal Medicine showed that type 2 diabetes patients treated with multiple daily insulin injections reduced their mean A1C levels from 8.5% at baseline to 7.5% 12 weeks after using continuous glucose monitoring, compared with dropping to 7.9% among those in the blood glucose meter testing only group. Researchers used a cohort of 158 diabetes patients and found that the median time spent in the range of 3.89 to 9.99 mmol/L was 802 minutes per day at baseline to 882 minutes per day at 24 weeks in the CGM group, compared with 794 minutes at baseline to 836 minutes per day in the control group.

Medscape (free registration) (8/21) 

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

More sleep may lower type 2 diabetes risk in youths

Nine- and 10-year-olds who got an additional hour of sleep during weekdays had a 2.9% reduction in insulin resistance, 0.24% lower fasting glucose and 0.19% lower body mass index, which are risk factors for type 2 diabetes, compared with those who got less sleep, UK researchers reported in Pediatrics. However, the findings didn’t show a link between sleep duration and HbA1C levels or cardiovascular risk.

The New York Times (free-article access for SmartBrief readers) (8/15), MedPage Today (free registration) (8/15)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Study finds 2-hour postload glucose effective in predicting CV events in CAD

Researchers found that two-hour postload glucose was a better predictor of cardiovascular events among patients with coronary artery disease but without previously known diabetes than A1C or fasting plasma glucose. The findings in Diabetes Care, based on 3,775 patients, revealed that an A1C between 5.7% and 6.5% and 2h-PG between 7.8 and 11.0 mmol/L were independent predictors of incident diabetes.

Endocrinology Advisor (7/20)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Researchers examine prevalence of DPN among youths with diabetes

Researchers examine prevalence of DPN among youths with diabetes
Seven percent of young type 1 diabetes patients and 22% of young type 2 diabetes patients had diabetic peripheral neuropathy, and the risk of DPN was associated with glycemic control in patients with type 1 diabetes, but not among those with type 2 diabetes, according to a study in Diabetes Care. Researchers used a cohort of 1,992 youths with diabetes and found that there was an almost twofold increase in the prevalence of DPN with every 5-year increase in diabetes duration in both type 1 and type 2 diabetes patients.

Medscape (free registration) (7/21)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Upcoming Events

The Diabates and Metabolism Seminar Series will resume in the Fall.

Other Events

Cystic Fibrosis Research Seminar Series

Annual Retreat (Cystic Fibrosis Research Seminar Series)

09-27-2017 - 8:00 am
UW Center for Urban Horticulture
3501 NE 41st Street
Seattle, WA 98195

 

Location: UW Center for Urban Horticulture

Dept of Medicine Grand Rounds

TITLE TBD (Dept of Medicine Grand Rounds)

09-28-2017 - 8:00 am
UW Health Sciences Building
1959 NE Pacific St
Seattle, WA 98195

Nazem Akoum, MD, MS
Associate Professor
Department of Medicine, Division of Cardiology
Director, UW Atrial Fibrillation Program
UW School of Medicine

Room Location: T-625

Diabetes Research Center

Short-Course on Quantitative Digital Pathology (DRC)

10-23-2017 - 4:00 pm
UW SLU
850 Republican St
Seattle, WA 98109

The 2017 Short-Course on Quantitative Digital Pathology is an intensive course focused on the principles, and methods used in stereology and image analysis to obtain accurate non-biased data from tissue sections. This is a unique opportunity to interact with experts in the field of stereology and image analysis. Students will be introduced to processes that dramatically improve the efficiency and accuracy of stereology and quantitative image analysis, such as whole slide digital imaging and powerful analysis software. The workshop is five days of lectures, interactive sessions and hands-on experience.

For more information, please contact:
Charles W. Frevert, DVM, ScD
cfrevert@uw.edu
or
Brian Johnson
brianj18@uw.edu

Location: SLU Campus

Download Flyer